peroxynitrous acid has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darley-Usmar, V; Giordano, S; Zhang, J | 1 |
| Chen, Q; Djaldatti, R; Giasson, BI; Ischiropoulos, H; Jackson-Lewis, V; Lee, VM; Przedborski, S; Souza, JM; Vila, M; Vukosavic, S | 1 |
1 review(s) available for peroxynitrous acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.
Topics: Aging; Animals; Antioxidants; Antiparkinson Agents; Autophagy; Brain; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Lipid Peroxidation; Lysosomes; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Parkinsonian Disorders; Peroxynitrous Acid | 2014 |
1 other study(ies) available for peroxynitrous acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; beta-Synuclein; Cell Line; Corpus Striatum; Disease Models, Animal; Humans; Kidney; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Oxidation-Reduction; Parkinsonian Disorders; Peroxynitrous Acid; Precipitin Tests; Protein Processing, Post-Translational; Synaptophysin; Synucleins; Transfection; Tyrosine | 2001 |